Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Margin

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 0.531.01-1.915.603.92

What is the latest Core EBITDA Margin ratio of GENPHARMASEC ?

The latest Core EBITDA Margin ratio of GENPHARMASEC is 0.53 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar20240.53
Mar20231.01
Mar2022-1.91
Mar20215.60
Mar20203.92

How is Core EBITDA Margin of GENPHARMASEC Trending?

Years Core EBITDA Margin % Change
Mar2024 0.53
-47.52
Mar2023 1.01
Positive
Mar2022 -1.91
Negative
Mar2021 5.6
42.86
Mar2020 3.92 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Margin ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹124.0 Cr -2.2% -26.1% -47.1% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,167.4 Cr -8.1% -18.1% 78.6% Stock Analytics
KIRI INDUSTRIES ₹2,994.0 Cr -12.3% -6.5% 53.5% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,247.3 Cr -2.2% -9.5% 11% Stock Analytics
BODAL CHEMICALS ₹771.7 Cr -2.9% -5.3% -15.6% Stock Analytics
BHAGERIA INDUSTRIES ₹752.2 Cr -10.2% -3.2% 7% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-2.2%

-26.1%

-47.1%

SENSEX

-2.5%

-1.4%

6.1%


You may also like the below Video Courses